• 1
    CDC. National Diabetes Fact Sheet: General Information and National Estimates on Diabetes in the United States. U.S. Department of Health and Human Services, Center for Disease Control and Prevention, 2007.
  • 2
    NIH. Estimates of Funding for Various Diseases, Conditions, Research Areas. National Institutes of Health, Department of Health and Humans Services, 2008.
  • 3
    Hansen BC, Bodkin NL. Heterogeneity of insulin responses: phases leading to type 2 (non-insulin-dependent) diabetes mellitus in the rhesus monkey. Diabetologia 1986;29:713719.
  • 4
    Ludlage E, Mansfield K. Clinical care and diseases of the common marmoset (Callithrix jacchus). Comp Med 2003;53:369382.
  • 5
    Abbott DH, Barnett DK, Colman RJ, Yamamoto ME, Schultz-Darken NJ. Aspects of common marmoset basic biology and life history important for biomedical research. Comp Med 2003;53:339350.
  • 6
    Roth GS, Mattison JA, Ottinger MA et al. Aging in rhesus monkeys: relevance to human health interventions. Science 2004;305:14231426.
  • 7
    Tardif SD, Smucny DA, Abbott DH et al. Reproduction in captive common marmosets (Callithrix jacchus). Comp Med 2003;53:364368.
  • 8
    Tardif SD, Power ML, Ross CN et al. Characterization of obese phenotypes in a small nonhuman primate, the common marmoset (Callithrix jacchus). Obesity (Silver Spring) 2009;17:14991505.
  • 9
    Fong TM. Targeting metabolic syndrome. Expert Opin Investig Drugs 2004;13:12031206.
  • 10
    Kelemen LE. GI Epidemiology: nutritional epidemiology. Aliment Pharmacol Ther 2007;25:401407.
  • 11
    Jen K-LC, Hansen BC. Glucose disappearance rate in rhesus monkeys: Some technical considerations. Am J Primatol 1988;14:153166.
  • 12
    Stary HC, Chandler AB, Glagov S et al. A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation 1994;89:24622478.
  • 13
    Stary HC, Chandler AB, Dinsmore RE et al. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation 1995;92:13551374.
  • 14
    Kramer J, Moeller EL, Hachey A, Mansfield KG, Wachtman LM. Differential expression of GLUT2 in pancreatic islets and kidneys of New and Old World nonhuman primates. Am J Physiol Regul Integr Comp Physiol 2009;296:R786R793.
  • 15
    Juan-Sallés C, Marco A, Ramos-Vara JA et al. Islet hyperplasia in callitrichids. Primates 2002;43:179190.
  • 16
    Brissova M, Fowler MJ, Nicholson WE et al. Assessment of human pancreatic islet architecture and composition by laser scanning confocal microscopy. J Histochem Cytochem 2005;53:10871097.
  • 17
    Wieczorek G, Pospischil A, Perentes E. A comparative immunohistochemical study of pancreatic islets in laboratory animals (rats, dogs, minipigs, nonhuman primates). Exp Toxicol Pathol 1998;50:151172.
  • 18
    Daly ME, Vale C, Walker M, Alberti KG, Mathers JC. Dietary carbohydrates and insulin sensitivity: a review of the evidence and clinical implications. Am J Clin Nutr 1997;66:10721085.
  • 19
    Marshall JA, Hamman RF, Baxter J. High-fat, low-carbohydrate diet and the etiology of non-insulin-dependent diabetes mellitus: the San Luis Valley Diabetes Study. Am J Epidemiol 1991;134:590603.
  • 20
    Sahyoun NR, Anderson AL, Tylavsky FA et al.; Health, Aging, and Body Composition Study. Dietary glycemic index and glycemic load and the risk of type 2 diabetes in older adults. Am J Clin Nutr 2008;87:126131.
  • 21
    Storlien LH, Baur LA, Kriketos AD et al. Dietary fats and insulin action. Diabetologia 1996;39:621631.
  • 22
    Yang EJ, Kerver JM, Park YK et al. Carbohydrate intake and biomarkers of glycemic control among US adults: the third National Health and Nutrition Examination Survey (NHANES III). Am J Clin Nutr 2003;77:14261433.
  • 23
    Boden G. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes 1997;46:310.
  • 24
    Kamada T, Yamashita T, Baba Y et al. Dietary sardine oil increases erythrocyte membrane fluidity in diabetic patients. Diabetes 1986;35:604611.
  • 25
    Ahrén B. Type 2 diabetes, insulin secretion and β-cell mass. Curr Mol Med 2005;5:275286.
  • 26
    Bonner-Weir S, Deery D, Leahy JL, Weir GC. Compensatory growth of pancreatic β-cells in adult rats after short-term glucose infusion. Diabetes 1989;38:4953.
  • 27
    Butler AE, Janson J, Bonner-Weir S et al. β-cell deficit and increased β-cell apoptosis in humans with type 2 diabetes. Diabetes 2003;52:102110.
  • 28
    Del Prato S, Wishner WJ, Gromada J, Schluchter BJ. β-cell mass plasticity in type 2 diabetes. Diabetes Obes Metab 2004;6:319331.
  • 29
    Flier SN, Kulkarni RN, Kahn CR. Evidence for a circulating islet cell growth factor in insulin-resistant states. Proc Natl Acad Sci USA 2001;98:74757480.
  • 30
    Milburn JL Jr, Hirose H, Lee YH et al. Pancreatic β-cells in obesity. Evidence for induction of functional, morphologic, and metabolic abnormalities by increased long chain fatty acids. J Biol Chem 1995;270:12951299.
  • 31
    Seino S, Steiner DF, Bell GI. Sequence of a New World primate insulin having low biological potency and immunoreactivity. Proc Natl Acad Sci USA 1987;84:74237427.
  • 32
    Wallis M. New insulin-like growth factor (IGF)-precursor sequences from mammalian genomes: the molecular evolution of IGFs and associated peptides in primates. Growth Horm IGF Res 2009;19:1223.
  • 33
    Shah P, Vella A, Basu A et al. Lack of suppression of glucagon contributes to postprandial hyperglycemia in subjects with type 2 diabetes mellitus. J Clin Endocrinol Metab 2000;85:40534059.
  • 34
    Shah P, Basu A, Basu R, Rizza R. Impact of lack of suppression of glucagon on glucose tolerance in humans. Am J Physiol 1999;277:E283E290.
  • 35
    Reiser S, Handler HB, Gardner LB et al. Isocaloric exchange of dietary starch and sucrose in humans. II. Effect on fasting blood insulin, glucose, and glucagon and on insulin and glucose response to a sucrose load. Am J Clin Nutr 1979;32:22062216.
  • 36
    Thorburn AW, Storlien LH, Jenkins AB, Khouri S, Kraegen EW. Fructose-induced in vivo insulin resistance and elevated plasma triglyceride levels in rats. Am J Clin Nutr 1989;49:11551163.
  • 37
    Storlien LH, Oakes ND, Pan DA, Kusunoki M, Jenkins AB. Syndromes of insulin resistance in the rat. Inducement by diet and amelioration with benfluorex. Diabetes 1993;42:457462.
  • 38
    Reiser S, Bohn E, Hallfrisch J et al. Serum insulin and glucose in hyperinsulinemic subjects fed three different levels of sucrose. Am J Clin Nutr 1981;34:23482358.
  • 39
    Sourij H, Schmoelzer I, Dittrich P et al. Insulin resistance as a risk factor for carotid atherosclerosis: a comparison of the Homeostasis Model Assessment and the short insulin tolerance test. Stroke 2008;39:13491351.
  • 40
    Razani B, Chakravarthy MV, Semenkovich CF. Insulin resistance and atherosclerosis. Endocrinol Metab Clin North Am 2008;37:60321, viii.
  • 41
    Crook D, Weisgraber KH, Boyles JK, Mahley RW. Isolation and characterization of plasma lipoproteins of common marmoset monkey. Comparison of effects of control and atherogenic diets. Arteriosclerosis 1990;10:633647.
  • 42
    Turley SD, Spady DK, Dietschy JM. Identification of a metabolic difference accounting for the hyper- and hyporesponder phenotypes of cynomolgus monkey. J Lipid Res 1997;38:15981611.
  • 43
    Tardif SD, Richter CB. Competition for a desired food in family groups of the common marmoset (Callithrix jacchus) and the cotton-top tamarin (Saguinus oedipus). Lab Anim Sci 1981;31:5255.